Aynur Eleanor Ergun

Head Of Biopharmaceutical Operations at Swedish Orphan Biovitrum

Aynur Eleanor Ergun has extensive work experience in various positions. Aynur Eleanor worked as the Head of Biopharmaceutical Operations at Sobi - Swedish Orphan Biovitrum AB (publ) from April 2016 onwards. Prior to that, they founded and served as the Chairman of the international charity organization, Spread Light, starting from February 2011. Aynur also had several roles at AstraZeneca, including FM Director, Supplier Relationship Manager for the UK and Sweden, Associate Director, First Line Manager, Quality Assurance Inspector and Officer for Tablets and Sterile Liquids, and Quality Compliance Officer. Aynur Eleanor worked at AstraZeneca from September 2001 to April 2016. Additionally, Aynur held the position of CEO at Safirdruvan Konferens AB from January 2012 to March 2016, where they were responsible for creative direction, product design, concept management, and new business development. Lastly, they served as Vice President and Vice Chairman for an international youth charity organization, Melthodhaye, from June 2011 to April 2014. In this role, they were in charge of personal and organizational development, as well as creative product and process development.

Aynur Eleanor Ergun has a diverse education history. Aynur Eleanor first pursued a Bachelor of Science (BSc) degree in Business, Supply Professionalism Program at the University of Warwick - Warwick Business School from 2009 to 2012. During that time, they also completed a program at PDP Dains, Consulting Agency UK, focusing on personal and organizational effectiveness and coaching in forming high performance teams. Aynur Eleanor further enhanced their knowledge in the field of business development and profitability of production through a program at Pharm Alliance, Consulting Agency UK, from 2010 to 2011. Prior to these experiences, Aynur completed a Master of Science degree in Chemistry and Economics at Stockholm University. Additionally, they engaged in leadership and personal development studies at KTH Royal Institute of Technology. In 2020, Aynur participated in a program offered by Michaël Berglund Board & Leadership Services focusing on professional board work.

Links

Previous companies

AstraZeneca logo

Timeline

  • Head Of Biopharmaceutical Operations

    April, 2016 - present